Navigation Links
Late-breaking observational data show patients with type 2 diabetes taking JANUVIA® (sitagliptin) and metformin initiated insulin therapy at a slower rate compared to patients taking a sulfonylurea and metformin
Date:6/14/2014

WHITEHOUSE STATION, N.J., June 14, 2014 Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a late-breaking observational study that assessed the differences in time to initiation of insulin use and the proportion of the population initiating insulin among patients with type 2 diabetes taking the combination of JANUVIA (sitagliptin) and metformin, and patients taking the combination of a sulfonylurea and metformin. In this study, patients treated with a combination of JANUVIA and metformin initiated insulin therapy at a slower rate during the period of observation than patients treated with a combination of sulfonylurea and metformin.

"Type 2 diabetes is a progressive disease, so that over time many patients need to add insulin to their treatment regimens to maintain blood sugar control," said Peter Stein, M.D., vice president, Clinical Research for diabetes and endocrinology, Merck Research Laboratories. "This study provides insight about different oral treatment regimens and their possible effect on initiation of insulin under real-world conditions. Real-world research is an important complement to clinical trials as we seek to improve patient health outcomes."

JANUVIA is indicated, as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus. JANUVIA should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. JANUVIA has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk of developing pancreatitis while taking JANUVIA. JANUVIA is contraindicated in patients with a history of a serious hypersensitivity reaction to sitagliptin, such as anaphylaxis or angioedema.

Results from "Assessing time to insulin use among type 2 diabetes patients treated with sitagliptin or sulfonylurea plus metformin dual therapy"
'/>"/>

Contact: Pam Eisele
267-305-3558

Kim Hamilton
908-423-6831

Justin Holko
908-423-5088

Merck
Source:Eurekalert


Page: 1 2 3 4 5

Related medicine news :

1. Hot Line IV: Late-breaking trials on heart failure and acute coronary syndrome
2. A large, observational study of common gout treatment allopurinol shows less than half of patients reach recommended treatment goal
3. New post-hoc analysis shows patients with type 2 diabetes undergoing intensification of insulin therapy experienced less nighttime hypoglycemia while being treated with Januvia (Sitagliptin) compared to placebo
4. BRCA test results affect patients breast cancer surgery plans
5. Genotyping can predict disease outcomes in rheumatoid arthritis patients
6. Ipilimumab in advanced melanoma: added benefit for non-pretreated patients not proven
7. Recreational football can treat hypertensive and type 2 diabetes patients
8. Low cholesterol linked with worse survival in patients with kidney cancer
9. One-third of psoriatic arthritis patients are not receiving optimal dosing of adalimumab
10. Higher disease activity scores in obese RA patients
11. First clinical diabetes registry to provide seamless view of patients across specialties
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... (PRWEB) August 30, 2014 The ... Nutrition and Pharameuticals. Nutraceuticals is a source of ... ingredients from natural food sources. Nutraceutical ingredients have ... to the human body. Nutraceutical health products include ... fortified foods and more. Although nature is the ...
(Date:8/30/2014)... Acne is a common problem millions of American cope ... than a daily nuisance, for some, it can have a crippling ... even lead to dramatic mood swings and depression. , Those ... up their skin. In some cases, that can make the problem ... error, those on a quest for clearer skin can now view ...
(Date:8/30/2014)... 30, 2014 Continuing to meet the ... expanding with the addition of a new doctor and ... has provided leading-edge skin care in Grand Rapids since ... , “As a doctor, my passion is making sure ... with Forefront Dermatology, I’m better able to focus on ...
(Date:8/30/2014)... a plant-based medication commonly used to treat gout, ... in reducing potential complications from this type of ... gastrointestinal adverse effects, according to a study published ... released early online to coincide with its presentation ... Common complications after cardiac surgery include postpericardiotomy syndrome ...
(Date:8/30/2014)... August 30, 2014 The federal ... lawsuits ( http://www.injurybeacon.com/transvaginal-mesh/ ) filed against Boston Scientific ... four cases selected for one of the proceeding’s ... August 18, 2014, U.S. District Judge Joseph R. ... disagrees with Boston Scientific’s contention that a consolidated ...
Breaking Medicine News(10 mins):Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 3Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 4Health News:Acne Treatment Reviews Added to Popular Treatment Website 2Health News:Expanding Care at the Forefront of Dermatology 2Health News:Medication shows mixed results in reducing complications from cardiac surgery 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3
... (WASHINGTON, June 4, 2009) The American Society of ... its 2009 Minority Medical Student Award Program (MMSAP), which ... hematology research. Under the program, each award recipient will ... career development mentor, travel stipends to attend the ASH ...
... , MENTOR, Ohio, June 5 Join STERIS Isomedix Services ... critical to success in medical device sterilization ... 23, will provide attendees the opportunity to learn about sterilization ... , In addition to the TechTeam experts from STERIS Isomedix ...
... leader in pain prescription monitoring, has announced the appointment of ... Contracting. Hurley will oversee the company,s contracting activities and ... are thrilled to have Sean on board," said Ancelmo E. ... commitment to provide our payors with both data and tools ...
... the start, expert says , FRIDAY, June 5 (HealthDay News) ... the summer sun, but parents should remember that no tan ... form a tan, you will have ultraviolet radiation damage," Dr. ... Hospital, said in a news release from the northern California ...
... Dad consume has little effect on children,s choices, study ... eating habits don,t seem to influence their children,s food ... suggests. , "We found that the resemblance in dietary ... senior author Dr. Youfa Wang, an associate professor of ...
... Healthcare Informatics as the number 48 healthcare IT company by revenue ... Inc. (Nasdaq: IFLG ), a leading technology ... today announced that the company has been named to ... the fourth time in five years. , , (Logo: ...
Cached Medicine News:Health News:Minority medical students receive support to pursue hematology research 2Health News:Medical Device Sterilization Seminar Offered by STERIS Isomedix Services 2Health News:Medical Device Sterilization Seminar Offered by STERIS Isomedix Services 3Health News:Sean Hurley Joins Ameritox as Vice President for Insurance and Managed Care Contracting 2Health News:Wear Sunscreen for Lifelong Benefits 2Health News:Parental Eating Habits Don't Rub Off on Kids 2Health News:InfoLogix Named as One of the Top 50 Healthcare Information Technology Companies in the World 2Health News:InfoLogix Named as One of the Top 50 Healthcare Information Technology Companies in the World 3
(Date:8/29/2014)... -- Research and Markets  has announced the addition ... Market 2014-2018" report to their offering. ... that connect, support, or surround bones. There are several ... cartilage, fascia, and other fibrous tissues. Repetitive use, accidents, ... result in wear and tear in these tissues. Orthopedic ...
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces that a ... catalogue: North America Aesthetic Lasers and ... http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html North America ... 2020 Summary GlobalData,s new report, "North ... to 2020", provides key market data on the ...
(Date:8/28/2014)... , Aug. 28, 2014 ... report is available in its catalogue: ... 2014-2024 http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html ... – discover technological and commercial prospects What ... delivery market? Visiongain,s brand new report shows ...
Breaking Medicine Technology:Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18
... , , FREEHOLD, N.J. , Feb. 3 ... it has engaged Morgan Joseph & Co. Inc., ... to maximize shareholder value with respect to Speedus Corp,s subsidiary, ... medical software to identify and classify suspected systolic and diastolic ...
... , HOUSTON and DALLAS , ... along with the company,s management, medical staff, and employees, are making multiple ... earthquake in Haiti . , In response to the magnitude ... million homeless, and over 195,000 awaiting medical attention, First Choice owner ...
Cached Medicine Technology:Speedus Engages Morgan Joseph to Evaluate Strategic Alternatives for Zargis Subsidiary 2Speedus Engages Morgan Joseph to Evaluate Strategic Alternatives for Zargis Subsidiary 3First Choice ER to Donate Over $15,000 in Medical Supplies to Haitian Earthquake Victims 2
... test device provides clear, reliable ... results can be determined in ... positive results require only 8 ... sample application will dependably and ...
... are available in 14 configurations including the ... Microgenics Antibody Technology, the SureStep™ MDMA (Ecstasy) ... immunoassay targeted to detect MDMA that has ... but no cross-reactivity to any isomer of ...
... are available in 14 configurations including the ... Microgenics Antibody Technology, the SureStep™ MDMA (Ecstasy) ... immunoassay targeted to detect MDMA that has ... but no cross-reactivity to any isomer of ...
... QuickScreen™ multi-panel dip cards offer minimal exposure ... of any conceivable combination of 9 different ... your drug testing program. Just dip the ... timer tells you when to read the ...
Medicine Products: